Bicycle Therapeutics (BCYC) Net Margin (2018 - 2025)
Historic Net Margin for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to 503.66%.
- Bicycle Therapeutics' Net Margin rose 13947700.0% to 503.66% in Q3 2025 from the same period last year, while for Sep 2025 it was 4369.94%, marking a year-over-year increase of 70993600.0%. This contributed to the annual value of 14085.92% for FY2024, which is 106771600.0% down from last year.
- Latest data reveals that Bicycle Therapeutics reported Net Margin of 503.66% as of Q3 2025, which was up 13947700.0% from 2703.84% recorded in Q2 2025.
- In the past 5 years, Bicycle Therapeutics' Net Margin registered a high of 300.39% during Q4 2023, and its lowest value of 2703.84% during Q2 2025.
- Over the past 5 years, Bicycle Therapeutics' median Net Margin value was 608.94% (recorded in 2025), while the average stood at 781.25%.
- As far as peak fluctuations go, Bicycle Therapeutics' Net Margin skyrocketed by 18977400bps in 2022, and later plummeted by -22785400bps in 2025.
- Quarter analysis of 5 years shows Bicycle Therapeutics' Net Margin stood at 2254.62% in 2021, then skyrocketed by 84bps to 356.88% in 2022, then surged by 184bps to 300.39% in 2023, then plummeted by -43bps to 170.76% in 2024, then crashed by -395bps to 503.66% in 2025.
- Its Net Margin was 503.66% in Q3 2025, compared to 2703.84% in Q2 2025 and 608.94% in Q1 2025.